Literature DB >> 20714879

Analysis of phosphatidylinositol 3-kinase activation in the adipose tissue of gestational diabetes mellitus patients and insulin resistance.

Yongli Chu1, Wenjuan Liu, Qing Cui, Guijiao Feng, Yan Wang, Xueqiang Jiang.   

Abstract

The P85 regulatory subunit protein and gene expression and P110 catalylic subunit activity of phosphatidylinositol 3-kinase (PI-3K) were investigated in adipose tissue of patients with gestational diabetes mellitus (GDM) in order to explore the molecular mechanisms of insulin resistance (IR) of GDM. Samples from patients with GDM (n=50), and controls (n=50) were collected. Fasting insulin (FIN) was determined by radioimmunoassay. Fasting plasma glucose (FPG) was measured by oxidase assay. Western blot technique was used to detect the levels of PI-3K P85 subunit in adipose tissues of patients with GDM. The mRNA expression of PI-3K P85 subunit was detected by reverse transcription polymerase chain reaction (RT-PCR) method in the adipose tissue. PI-3K activity was examined by immunoprecipitation, thin-layer chromatography and gamma scintillation counting. The results were analyzed statistically. It was found that the levels of FPG, FIN and HOMA-IR in GDM group were significantly higher than those in control group (all P<0.01). There was no significant difference in the protein and gene expression of PI-3K P85 subunit between GDM group and control group (P>0.05). PI-3K activity was significantly decreased to 82.89% in GDM group as compared with control group (P<0.01) and negatively correlated with HOMA-IR (r=-0.75, P<0.01). It was concluded that PI-3K in GDM patients may be involved in the insulin signaling pathway, resulting in IR of GDM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20714879     DOI: 10.1007/s11596-010-0458-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  24 in total

1.  Early pregnancy insulin resistance and subsequent gestational diabetes mellitus.

Authors:  Karen V Smirnakis; Abelardo Martinez; Karen Hsu Blatman; Myles Wolf; Jeffrey L Ecker; Ravi Thadhani
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

2.  Differences in insulin sensitivity in pregnant women with overweight and gestational diabetes mellitus.

Authors:  Satoko Endo; Kazuhisa Maeda; Masanori Suto; Takashi Kaji; Mikio Morine; Toshiko Kinoshita; Toshiyuki Yasui; Minoru Irahara
Journal:  Gynecol Endocrinol       Date:  2006-06       Impact factor: 2.260

3.  Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus.

Authors:  Michelle Colomiere; Michael Permezel; Clyde Riley; Gernot Desoye; Martha Lappas
Journal:  Eur J Endocrinol       Date:  2009-01-29       Impact factor: 6.664

4.  Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia.

Authors:  R Retnakaran; Y Qi; P W Connelly; M Sermer; A J Hanley; B Zinman
Journal:  Diabetologia       Date:  2009-11-24       Impact factor: 10.122

5.  Increased risk of macrosomia among overweight women with high gestational rise in fasting glucose.

Authors:  Nanna Voldner; Elisabeth Qvigstad; Kathrine Frey Frøslie; Kristin Godang; Tore Henriksen; Jens Bollerslev
Journal:  J Matern Fetal Neonatal Med       Date:  2010-01

6.  Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus.

Authors:  Marco Scioscia; Khalid Gumaa; Luigi E Selvaggi; Charles H Rodeck; Thomas W Rademacher
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

7.  Beta-cell function and insulin resistance in pregnancy and their relation to fetal development.

Authors:  Sidhartha Das; Manas Kumar Behera; Sujata Misra; Anoj Kumar Baliarsihna
Journal:  Metab Syndr Relat Disord       Date:  2010-02       Impact factor: 1.894

8.  Leptin, insulin, and glucose serum levels in large-for-gestational-age infants of diabetic and non-diabetic mothers.

Authors:  M Martha Vela-Huerta; Edgar Ulises San Vicente-Santoscoy; Juan Manuel Guizar-Mendoza; Norma Amador-Licona; Carlos Aldana-Valenzuela; Javier Hernnández
Journal:  J Pediatr Endocrinol Metab       Date:  2008-01       Impact factor: 1.634

9.  Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus.

Authors:  P Kleiblova; I Dostalova; M Bartlova; Z Lacinova; I Ticha; V Krejci; D Springer; Z Kleibl; M Haluzik
Journal:  Mol Cell Endocrinol       Date:  2009-08-12       Impact factor: 4.102

10.  Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects.

Authors:  L J Goodyear; F Giorgino; L A Sherman; J Carey; R J Smith; G L Dohm
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

View more
  2 in total

1.  Visceral adipose tissue alteration of PI3KR1 expression is associated with gestational diabetes but not promoter DNA methylation.

Authors:  Rebecca C Rancourt; Raffael Ott; Karen Schellong; Kerstin Melchior; Thomas Ziska; Wolfgang Henrich; Andreas Plagemann
Journal:  Adipocyte       Date:  2019-12       Impact factor: 4.534

2.  circMAP3K4 regulates insulin resistance in trophoblast cells during gestational diabetes mellitus by modulating the miR-6795-5p/PTPN1 axis.

Authors:  Runyu Du; Na Wu; Yu Bai; Lei Tang; Ling Li
Journal:  J Transl Med       Date:  2022-04-21       Impact factor: 8.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.